
Preparing a quiet space
A second official government anchor for Kratom searches, useful for loved ones and users seeking plain-language safety context.
Source Intelligence
Creator
NCCIH
Duration
9 min read
Transcript
summary only
Audience
People in recovery, Loved ones
Recovery Pathway
Clinical education, Harm reduction

NCCIH's kratom overview covers reported use, current research limits, safety concerns, addiction potential, withdrawal, and product contamination issues.
Open OriginalAI Summary
This plain-language government page helps answer Kratom safety questions and should sit beside NIDA research and local treatment options.
Key Takeaways
Transcript
Status
summary only
Official NCCIH public-domain overview metadata for kratom safety and research limits.
Use for plain-language government context in Kratom searches.
Chapters
0:00
Background
Explains what kratom is and why people report using it.
3:30
Bottom line
Summarizes limited research and lack of approved medical use.
7:10
Safety
Highlights dependence, withdrawal, side effects, and contamination concerns.
Related Knowledge
Kratom Research Topic
NIDA's research topic page for kratom, including reported uses, dependence questions, withdrawal, and the status of emerging evidence.
What is Harm Reduction?
A concise NIDA explainer on harm reduction as a public health strategy for reducing risk and keeping people connected to care.
AA Big Book Study: Clinical Guideline Overview
Clinical guideline metadata for education, partner trust, scope boundaries, and official-source review.
Recovery Book Index: Clinical Guideline Overview
Clinical guideline metadata for education, partner trust, scope boundaries, and official-source review.
Kratom and 7-OH: What Clinicians Need to Know
A clinical podcast episode on kratom, 7-hydroxymitragynine, pharmacology, withdrawal, addiction potential, and treatment concerns.
Kratom Science Podcast 81: Dr. Kirsten Smith of NIDA Returns
A long-form podcast interview with Dr. Kirsten Smith discussing kratom research, dependence, policy, and emerging evidence.
Medications for Opioid Use Disorder
A NIDA explainer on FDA-approved medications for opioid overdose, withdrawal, cravings, and opioid use disorder treatment.
Congressional Briefing on Kratom Science and Policy
A long-form public briefing on kratom science, policy questions, and research perspectives with NIDA-linked expertise referenced in the panel context.